Barriers and facilitators to prescribing buprenorphine for treating opioid use disorder among emergency department and other practice setting physicians
Despite federal legislation intended to increase the prescribing of buprenorphine as medication for opioid use disorder (MOUD), such as the Drug Addiction Treatment Act (DATA) of 2000, most providers have continued to prescribe to some patients or to not prescribe at all. We aimed to determine the c...
Saved in:
| Main Authors: | James A. Swartz, Dana Franceschini, Nora M. Marino, Adrienne H. Call, Lisa Rosenberger, Sarah Whitehouse |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AIMS Press
2025-01-01
|
| Series: | AIMS Public Health |
| Subjects: | |
| Online Access: | https://www.aimspress.com/article/doi/10.3934/publichealth.2025005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterizing withdrawal from long-acting injectable buprenorphine: An observational case series
by: Victoria Hayes, et al.
Published: (2025-06-01) -
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01) -
Assessing buprenorphine treatment utilization and SAMHSA DATA waiver provider distribution in 2021: a real-world analysis in California
by: Yun Wang, et al.
Published: (2025-08-01) -
Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01) -
Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report
by: Ezioma Gbujie, et al.
Published: (2025-06-01)